Trump’s drugmaker deals may save economy $529B over 10 years, White House says
The administration says the plan could also cut Medicaid spending by $64.3 billion as Democrats question the unpublished deal terms.
- White House economists estimate President Donald Trump's deals with pharmaceutical companies could save $529 billion over 10 years by aligning U.S. prescription drug prices with international rates.
- Trump is leveraging his "most favored nation" policy to address affordability concerns, ensuring U.S. prescription drug costs are no longer dramatically higher than in other affluent nations.
- Americans spent $467 billion on prescription drugs in 2024, while The Congressional Budget Office estimated a similar plan could reduce prices by more than 5% over time.
- Senate Finance Committee Ranking Member Ron Wyden and Senate Democrats proposed a measure in April requiring the administration to disclose terms of the pharmaceutical agreements.
- Staff for Sen Bernie Sanders, I-Vt, analyzed 15 companies in the plan and found their profits jumped 66% over the past year, as critics argue pharmaceutical companies increased margins while working with the administration.
65 Articles
65 Articles
The White House projects billions in drug pricing deals. Democrats are skeptical.
The Trump administration has released lofty expectations about the state of the pharmaceutical industry, and not everyone appears to be a believer. Recent data from the White House predicted that the administration’s deals with drug companies could save the economy more than half a trillion dollars over the next decade. While Republicans are lauding this estimate, many Democrats are taking it with a grain of salt.‘Touted his drug pricing deals a…
Omaha World-Herald
The Billings GazetteAdministration: Drug deal will save $64.3B
The Trump Administration said Tuesday its "Most Favored Nation" drug pricing deal was expected to generate $64.3 billion in federal and state savings in the next 10 years.
White House: Trumps drugmaker deals may save economy $529B
WASHINGTON — White House economists estimate that President Donald Trump’s deals with pharmaceutical companies to drop some of their U.S. prescription drug prices to what they charge in other countries could save $529 billion over the next 10 years.
White House estimates Trump's Big Pharma dealmaking will save Americans $529 billion over the next 10 years
White House economists estimate that President Donald Trump’s deals with pharmaceutical companies to drop some of their U.S. prescription drug prices to what they charge in other countries could save $529 billion over the next 10 years. The analysis obtained by The Associated Press includes the first economy-wide projections behind a policy at the core of Trump’s pitch to voters going into November’s midterm elections for control of the House an…
Coverage Details
Bias Distribution
- 57% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
